Solid-state stability studies of crystal form of tebipenem / Alicja Talaczyńska, Kornelia Lewandowska, Piotr Garbacki, Przemysław Zalewski, Robert Skibiński, Andrzej Miklaszewski, Mikołaj Mizera, Judyta Cielecka-Piontek
Abstract The aim of this study was to determine the kinetic and thermodynamic parameters of tebipenem degradation in the solid state. The process was analyzed based on the results obtained by a high performance liquid chromatography (HPLC) method using ultraviolet diode-array detector (DAD)/electrospray ionization tandem mass spectrometry (Q-TOF-MS/MS), Fourier transform infrared spectroscopy (FT-IR) and Raman spectroscopic (RS) studies. In dry air, the degradation of tebipenem was a first-order reaction depending on the substrate concentration while at an increased relative air humidity tebipenem was degraded according to the kinetic model of autocatalysis. The thermodynamic parameters: energy of activation ( E a ), enthalpy (Δ H ≠a ) and entropy (Δ S ≠a ) of tebipenem degradation were calculated. Following a spectroscopic analysis of degraded samples of tebipenem, a cleavage of the β-lactam bond was proposed as the main degradation pathway, next confirmation using HPLC-Q-TOF-MS/MS method.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2016 |
---|---|
Erschienen: |
2016 |
Enthalten in: |
Zur Gesamtaufnahme - volume:42 |
---|---|
Enthalten in: |
Drug development and industrial pharmacy - 42(2016), 2, Seite 238- |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Talaczyńska, Alicja [VerfasserIn] |
---|
Links: |
FID Access [lizenzpflichtig] |
---|
Umfang: |
1 Online-Ressource (7 p) |
---|
doi: |
10.3109/03639045.2015.1044902 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
KFL001083171 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | KFL001083171 | ||
003 | DE-627 | ||
005 | 20230623202212.0 | ||
007 | cr uuu---uuuuu | ||
008 | 210608s2016 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3109/03639045.2015.1044902 |2 doi | |
035 | |a (DE-627)KFL001083171 | ||
035 | |a (KFL)prod_LgpH_10.3109/03639045.2015.1044902 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
084 | |a PHARM |q DE-84 |2 fid | ||
100 | 1 | |a Talaczyńska, Alicja |e verfasserin |4 aut | |
245 | 1 | 0 | |a Solid-state stability studies of crystal form of tebipenem |c Alicja Talaczyńska, Kornelia Lewandowska, Piotr Garbacki, Przemysław Zalewski, Robert Skibiński, Andrzej Miklaszewski, Mikołaj Mizera, Judyta Cielecka-Piontek |
264 | 1 | |c 2016 | |
300 | |a 1 Online-Ressource (7 p) | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Abstract The aim of this study was to determine the kinetic and thermodynamic parameters of tebipenem degradation in the solid state. The process was analyzed based on the results obtained by a high performance liquid chromatography (HPLC) method using ultraviolet diode-array detector (DAD)/electrospray ionization tandem mass spectrometry (Q-TOF-MS/MS), Fourier transform infrared spectroscopy (FT-IR) and Raman spectroscopic (RS) studies. In dry air, the degradation of tebipenem was a first-order reaction depending on the substrate concentration while at an increased relative air humidity tebipenem was degraded according to the kinetic model of autocatalysis. The thermodynamic parameters: energy of activation ( E a ), enthalpy (Δ H ≠a ) and entropy (Δ S ≠a ) of tebipenem degradation were calculated. Following a spectroscopic analysis of degraded samples of tebipenem, a cleavage of the β-lactam bond was proposed as the main degradation pathway, next confirmation using HPLC-Q-TOF-MS/MS method | ||
700 | 1 | |a Lewandowska, Kornelia |e verfasserin |4 aut | |
700 | 1 | |a Garbacki, Piotr |e verfasserin |4 aut | |
700 | 1 | |a Zalewski, Przemysław |e verfasserin |4 aut | |
700 | 1 | |a Skibiński, Robert |e verfasserin |4 aut | |
700 | 1 | |a Miklaszewski, Andrzej |e verfasserin |4 aut | |
700 | 1 | |a Mizera, Mikołaj |e verfasserin |4 aut | |
700 | 1 | |a Cielecka-Piontek, Judyta |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Drug development and industrial pharmacy |d Abingdon : Taylor & Francis Group, 1977 |g 42(2016), 2, Seite 238- |h Online-Ressource |w (DE-627)KFL000005975 |w (DE-600)2008903-X |w (DE-576)116897511 |x 1520-5762 |7 nnns |
773 | 1 | 8 | |g volume:42 |g year:2016 |g number:2 |g pages:238- |
856 | 4 | 0 | |u http://pharmazie.proxy.fid-lizenzen.de/fid/tandf-ejournals-pharmazie/doi.org/10.3109/03639045.2015.1044902 |m X:KFL |x Resolving-System |y FID Access |z lizenzpflichtig |
912 | |a ZDB-1-TFE | ||
912 | |a GBV_KFL | ||
912 | |a FID-PHARM | ||
912 | |a SSG-OLC-PHA | ||
935 | |i IMPORT_0628_prod_LgpH_01 | ||
951 | |a AR | ||
952 | |d 42 |j 2016 |e 2 |h 238- |